Article
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
Expert review of neurotherapeutics - 1 Sept 2008
Sodhi Monsheel, Wood Kimberly H, Meador-Woodruff James
Abstract excerpt
Schizophrenia is a debilitating lifelong disorder affecting up to 1% of the population worldwide, producing significant financial and emotional hardship for patients and their families. As yet, the causes of schizophrenia and the mechanism of action of antipsychotic drugs are unknown, and many patients do not respond well to currently available medications. Attempts to find risk factors for the disorder using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
